We are live on ! Find out more
Bleichroeder

Bleichroeder Portfolio holdings

AUM $1.02B Turnover 33.63%
1-Year Est. Return 33%
This Fund
S&P 500
This Quarter Est. Return
-3.15%
1 Year Est. Return
+33%
3 Year Est. Return
+222.49%
5 Year Est. Return
+219.92%
10 Year Est. Return
–
AUM
$1.02B
AUM Growth
+$457M
Cap. Flow
+$530M
Cap. Flow %
52.15%
Top 10 Hldgs %
44.01%
Holding
113
New
35
Increased
8
Reduced
7
Closed
3
Avg Time Held
2 years
Top 10 Avg Time Held
2.1 years
Top 20 Avg Time Held
1.4 years

Top Buys

Rank Stock Value
1
PSQL icon
Pasqal Holding SA Ordinary Share
PSQL
+$31.7M
2
MDLN icon
Medline Inc
MDLN
+$18.4M
3
AVGO icon
Broadcom
AVGO
+$17.9M
4
A icon
Agilent Technologies
A
+$17.9M
5
TSM icon
TSMC
TSM
+$17.7M

Top Sells

Rank Stock Value
1
IRD icon
Opus Genetics
IRD
+$2.08M
2
LIN icon
Linde
LIN
+$1.77M
3
OWLT icon
Owlet
OWLT
+$987K
4
FEAM icon
5E Advanced Materials
FEAM
+$638K
5
PYPL icon
PayPal
PYPL
+$220K

Sector Composition

Rank Sector Weight
1 Miscellaneous 23.67%
2 Technology 20.28%
3 Industrials 15.62%
4 Financials 13.79%
5 Healthcare 12.72%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
ROC icon
51
Rank One Computing Corp
ROC
$77.7M
$3.6M 0.35%
900,000
+400,000
+80% +$1.8M
2026 Q1
2 quarters
FLNT icon
52
Fluent
FLNT
$98.9M
$3.53M 0.35%
1,125,784
-17,073
-1% -$61.6K
2025 Q3
4 quarters
GNLX icon
53
Genelux
GNLX
$84.2M
$3.49M 0.34%
1,380,666
– –
2025 Q1
6 quarters
QQQ icon
54
Invesco QQQ Trust
QQQ
$467B
$3.43M 0.34%
4,640
– –
2025 Q2
5 quarters
JPM icon
55
JPMorgan Chase
JPM
$919B
$3.37M 0.33%
10,200
– –
2019 Q4
27 quarters
COGT icon
56
Cogent Biosciences
COGT
$4.97B
$3.2M 0.32%
100,000
– –
2026 Q2
1 quarter
DMAC icon
57
DiaMedica Therapeutics
DMAC
$474M
$3.16M 0.31%
382,317
– –
2023 Q2
13 quarters
PROK icon
58
ProKidney
PROK
$217M
$3.15M 0.31%
1,900,000
-100,000
-5% -$169K
2022 Q3
16 quarters
RNXT icon
59
RenovoRx
RNXT
$50.2M
$2.6M 0.26%
1,666,098
– –
2025 Q1
6 quarters
TV icon
60
Televisa
TV
$2.35B
$2.35M 0.23%
1,030,000
– –
2021 Q2
21 quarters
RVMDW icon
61
Revolution Medicines Inc Warrant
RVMDW
$2.29M 0.23%
200,000
– –
2023 Q4
11 quarters
CEPL icon
62
Capstone Energy Plus
CEPL
$87.6M
$2.04M 0.2%
+454,722
New +$3.33M
2026 Q3
0 quarters
PSQLW icon
63
Pasqal Holding SA Warrant
PSQLW
$1.61M 0.16%
+1,500,000
New +$2.23M
2026 Q3
0 quarters
IPWR icon
64
Ideal Power
IPWR
$34.3M
$1.57M 0.15%
400,000
– –
2024 Q1
10 quarters
TLPH icon
65
Talphera
TLPH
$47.1M
$1.52M 0.15%
1,307,787
– –
2025 Q1
6 quarters
SPIR icon
66
Spire Global
SPIR
$362M
$1.51M 0.15%
135,000
– –
2026 Q2
1 quarter
PROF icon
67
Profound Medical
PROF
$272M
$1.48M 0.15%
254,753
– –
2023 Q4
11 quarters
BRFH icon
68
Barfresh Food Group
BRFH
$7.5M
$1.29M 0.13%
1,404,044
+13,286
+1% +$19.9K
2022 Q1
18 quarters
LLYVK icon
69
Liberty Live Group Series C
LLYVK
$9.8B
$1.17M 0.12%
13,802
– –
2023 Q3
12 quarters
SINT icon
70
SiNtx Technologies
SINT
$10.1M
$1.17M 0.11%
523,013
– –
2026 Q2
1 quarter
IRD icon
71
Opus Genetics
IRD
$385M
$1.15M 0.11%
236,842
-500,000
-68% -$2.08M
2025 Q1
6 quarters
EYPT icon
72
EyePoint Inc
EYPT
$34.8M
$1.04M 0.1%
316,515
– –
2025 Q2
5 quarters
VENU icon
73
Venu Holding Corp
VENU
$63.9M
$852K 0.08%
600,000
– –
2025 Q3
4 quarters
QTI icon
74
QT Imaging Holdings
QTI
$27.6M
$806K 0.08%
316,667
– –
2026 Q1
2 quarters
RNTX icon
75
Rein Therapeutics
RNTX
$47.6M
$804K 0.08%
1,000,000
– –
2026 Q2
1 quarter

Similar funds

Bleichroeder's Q3 2026 Portfolio in Review

As of Q3 2026, Bleichroeder held 113 positions worth $1.02B, up 82% from $559M the previous quarter. Its ten largest holdings account for 44% of the portfolio.

Bleichroeder deployed $530M of net new capital in Q3 2026, opening 35 new positions and adding to 8 existing holdings. Its largest new stake was Pasqal Holding SA Ordinary Share: 3,496,313 shares worth $22.2M.

By sector, the portfolio is most concentrated in Miscellaneous at 24% of assets, down from 41% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was Opus Genetics, an estimated $2.08M trimmed.

  • Bleichroeder's largest Q3 2026 buy was Pasqal Holding SA Ordinary Share: 3,496,313 shares worth $22.2M.
  • Bleichroeder added most to S&P Global in Q3 2026, an estimated $16M increase.
  • Bleichroeder's biggest Q3 2026 reduction was Opus Genetics, cutting an estimated $2.08M.
  • Bleichroeder fully exited Owlet in Q3 2026, selling an estimated $987K.
  • Bleichroeder's ten largest holdings make up 44% of its $1.02B portfolio in Q3 2026.
  • Bleichroeder opened 35 new positions and closed 3 in Q3 2026.
  • Bleichroeder's portfolio value rose 82% quarter-over-quarter to $1.02B.

Based on Bleichroeder's 13F filing for Q3 2026, filed 13 Nov 2026.